Alessandra Alessi

965 total citations
39 papers, 572 citations indexed

About

Alessandra Alessi is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alessandra Alessi has authored 39 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Radiology, Nuclear Medicine and Imaging and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alessandra Alessi's work include Medical Imaging Techniques and Applications (8 papers), Bladder and Urothelial Cancer Treatments (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Alessandra Alessi is often cited by papers focused on Medical Imaging Techniques and Applications (8 papers), Bladder and Urothelial Cancer Treatments (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Alessandra Alessi collaborates with scholars based in Italy, United States and Netherlands. Alessandra Alessi's co-authors include Flavio Crippa, Emilio Bombardieri, Filippo de Braud, Roberto Agresti, Alice Lorenzoni, Gianluca Serafini, A. Bestetti, Filippo Pietrantonio, Maria Di Bartolomeo and Andrea Necchi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Alessandra Alessi

38 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alessandra Alessi Italy 14 219 206 153 122 102 39 572
Matilde Cacciatore Italy 12 123 0.6× 293 1.4× 154 1.0× 161 1.3× 166 1.6× 21 630
Yunxian Mo China 14 111 0.5× 205 1.0× 162 1.1× 168 1.4× 102 1.0× 32 562
Hui Wu China 13 218 1.0× 402 2.0× 143 0.9× 226 1.9× 81 0.8× 39 691
James M. McLoughlin United States 16 112 0.5× 287 1.4× 290 1.9× 231 1.9× 49 0.5× 41 705
Chiara Trentin Italy 14 149 0.7× 148 0.7× 158 1.0× 211 1.7× 134 1.3× 44 615
Ameya Puranik India 13 195 0.9× 144 0.7× 114 0.7× 165 1.4× 75 0.7× 105 551
Dali Han China 12 178 0.8× 126 0.6× 125 0.8× 166 1.4× 149 1.5× 34 535
Alin Chirindel United States 13 445 2.0× 279 1.4× 92 0.6× 263 2.2× 44 0.4× 30 792
Quan Zhu China 17 146 0.7× 136 0.7× 140 0.9× 403 3.3× 43 0.4× 56 654
Byoung Hyuck Kim South Korea 15 64 0.3× 228 1.1× 206 1.3× 198 1.6× 120 1.2× 70 564

Countries citing papers authored by Alessandra Alessi

Since Specialization
Citations

This map shows the geographic impact of Alessandra Alessi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Alessi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Alessi more than expected).

Fields of papers citing papers by Alessandra Alessi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandra Alessi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Alessi. The network helps show where Alessandra Alessi may publish in the future.

Co-authorship network of co-authors of Alessandra Alessi

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandra Alessi. A scholar is included among the top collaborators of Alessandra Alessi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandra Alessi. Alessandra Alessi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giannatempo, Patrizia, Valentina Guadalupi, Laura Marandino, et al.. (2023). Activity of cabozantinib (CABO) plus durvalumab (DURVA) in patients (pts) with advanced urothelial carcinoma (UC) or non-UC variant histologies (VH) after platinum chemotherapy: Interim results from the phase 2 ARCADIA trial.. Journal of Clinical Oncology. 41(16_suppl). 4578–4578. 4 indexed citations
2.
Aide, Nicolas, Dennis Vriens, Cornelis H. Slump, et al.. (2023). Development and External Validation of a PET Radiomic Model for Prognostication of Head and Neck Cancer. Cancers. 15(10). 2681–2681. 3 indexed citations
4.
Marandino, Laura, Daniele Raggi, Giuseppina Calareso, et al.. (2021). Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial. Clinical Genitourinary Cancer. 19(5). 457–465. 12 indexed citations
5.
Marandino, Laura, Antonella Capozza, Marco Bandini, et al.. (2020). [18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab. Urologic Oncology Seminars and Original Investigations. 39(4). 235.e15–235.e21. 11 indexed citations
6.
Giannatempo, Patrizia, Daniele Raggi, Laura Marandino, et al.. (2020). Pembrolizumab and nab-paclitaxel as salvage therapy for platinum-treated, locally advanced or metastatic urothelial carcinoma: interim results of the open-label, single-arm, phase II PEANUT study. Annals of Oncology. 31(12). 1764–1772. 31 indexed citations
8.
Luison, Elena, Ettore Seregni, Alice Lorenzoni, et al.. (2019). Anti-PSMA 124I-scFvD2B as a new immuno-PET tool for prostate cancer: preclinical proof of principle. Journal of Experimental & Clinical Cancer Research. 38(1). 326–326. 15 indexed citations
9.
Alessi, Alessandra, Alice Lorenzoni, Anna Cavallo, et al.. (2018). Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapy. La radiologia medica. 124(5). 414–421. 16 indexed citations
10.
Mennitto, Alessia, et al.. (2018). Management of Metastatic Collecting Duct Carcinoma: An Encouraging Result in a Patient Treated With Cabozantinib. Clinical Genitourinary Cancer. 16(3). e521–e523. 14 indexed citations
11.
Berenato, Rosa, Federica Morano, Filippo Pietrantonio, et al.. (2017). Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions. Oncology. 93(5). 279–286. 8 indexed citations
12.
Pietrantonio, Filippo, Daniele Oddo, Annunziata Gloghini, et al.. (2016). MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF -Mutated Colorectal Cancer. Cancer Discovery. 6(9). 963–971. 78 indexed citations
13.
Pietrantonio, Filippo, Maria Di Bartolomeo, Christian Cotsoglou, et al.. (2016). Perioperative Triplet Chemotherapy and Cetuximab in Patients With RAS Wild Type High Recurrence Risk or Borderline Resectable Colorectal Cancer Liver Metastases. Clinical Colorectal Cancer. 16(3). e191–e198. 11 indexed citations
14.
Giannatempo, Patrizia, Alessandra Alessi, Rosalba Miceli, et al.. (2014). Interim Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography for Early Metabolic Assessment of Therapeutic Response to Chemotherapy for Metastatic Transitional Cell Carcinoma. Clinical Genitourinary Cancer. 12(6). 433–439. 18 indexed citations
17.
Alessi, Alessandra, et al.. (2010). Incremental learning control of the DLR-HIT-Hand II during interaction tasks. PubMed. 14. 3194–3197. 1 indexed citations
18.
Crippa, Flavio, et al.. (2004). FDG-PET for axillary lymph node staging in primary breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 31(0). S97–S102. 50 indexed citations
19.
Castellani, Maria Rita, Alessandra Alessi, Giordano Savelli, & Emilio Bombardieri. (2003). The Role of Radionuclide Therapy in Medullary Thyroid Cancer. Tumori Journal. 89(5). 560–562. 7 indexed citations
20.
Bestetti, A., et al.. (2001). Post-stress end-systolic left ventricular dilation: a marker of endocardial post-ischemic stunning. Nuclear Medicine Communications. 22(6). 685–693. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026